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 Abstract.  Microdeletions of 3q29 have previously been 
reported, but the postulated reciprocal microduplication 
has only recently been observed. Here, cases from four fam-
ilies, two ascertained in Toronto (Canada) and one each 
from Edinburgh (UK) and Leiden (Netherlands), carrying 
microduplications of 3q29 are presented. These families 
have been characterized by cytogenetic and molecular tech-
niques, and all individuals have been further characterized 
with genome-wide, high density single nucleotide polymor-
phism (SNP) arrays run at a single centre (The Centre for 
Applied Genomics, Toronto). In addition to polymorphic 
copy-number variants (CNV), all carry duplications of 3q29 
ranging in size from 1.9 to 2.4 Mb, encompassing multiple 
genes and defining a minimum region of overlap of about 
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1.6 Mb bounded by clusters of segmental duplications that 
is remarkably similar in location to previously reported 
3q29 microdeletions. Consistent with other reports, the 
phenotype is variable, although developmental delay and 
significant ophthalmological findings were recurrent, sug-
gesting that dosage sensitivity of genes located within 3q29 
is important for eye and CNS development. We also con-
sider CNVs found elsewhere in the genome for their contri-
bution to the phenotype. We conclude by providing pre-
liminary guidelines for management and anticipatory care 
of families with this microduplication, thereby establishing 
a standard for CNV reporting. 
 Copyright © 2009 S. Karger AG, Basel 
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 Contiguous gene syndromes involving small chromo-
somal duplications are typically less frequently reported in 
comparison to their microdeletion counterparts. Although 
these rearrangements can both arise from a common mech-
anism involving nonallelic homologous recombination 
with region-specific low copy repeats (Lupski, 2004), micro-
duplication syndromes are usually less commonly recog-
nized, possibly due to ascertainment bias, milder and more 
variable phenotype, and technical limitations of cytogenet-
ics and fluorescent  in situ  hybridization (FISH). Well char-
acterized chromosomal regions shown to involve these re-
ciprocal duplication and deletion events include duplication 
of 17p11.2 causing a phenotype associated with moderate 
mental retardation and behavioural disturbances (Potocki 
et al., 2000), with the reciprocal microdeletion resulting in 
Smith-Magenis syndrome; microduplication of 22q11.2 
(Ensenauer et al., 2003) having a somewhat variable pheno-
type with cardiac malformation and features similar to the 
classical microdeletion 22q11.2 syndrome; microduplica-
tion of 15q11 ] q13 characterized by developmental delay 
and autism, reciprocal to deletions causing Prader-Willi/
Angelman syndromes (Dimitropoulos and Schultz, 2007), 
and microduplication of 7q11.23, which has been related to 
severe expressive language delay (Somerville et al .,  2005; 
Merritt and Lindor, 2008; Orellana et al .,  2008; Torniero et 
al .,  2008), while the corresponding deletion causes Wil-
liams-Beuren syndrome (Osborne et al .,  1996). Most recent-
ly, copy number variations (CNVs) in the form of microde-
letions and microduplications of chromosome 16p11.2 have 
also been observed in autism spectrum disorder (Kumar et 
al .,  2008; Marshall et al .,  2008; Weiss et al .,  2008).
 With the use of microarray-based techniques, increasing 
numbers of novel copy number variants are being discov-
ered both in apparently healthy control individuals (Redon 
et al .,  2006; Pinto et al .,  2007), and in patients with genetic 
disorders such as autism (Autism Genome Project Consor-
tium 2007; Sebat  et al .,  2007; Marshall et al .,  2008) and 
schizophrenia (Walsh et al .,  2008; Xu et al .,  2008). Improved 
resolution of these microarray platforms is resulting in 
greater power to detect ever smaller events, well below the 
level of resolution of conventional cytogenetic examination 
(Feuk et al .,  2006; Carter, 2007).
 A microdeletion syndrome on chromosome 3q29 was 
originally described in six patients (Willatt et al .,  2005). The 
common phenotypic features included a long narrow face, 
short philtrum, high nasal bridge, developmental and sig-
nificant speech delay. The microdeletion was approximate-
ly 1.5 Mb in length and was between identical low copy re-
peat sequences on either side of the deletion breakpoints. 
This suggests that this region is susceptible to nonallelic ho-
mologous recombination, which could result in reciprocal 
exchange events at chromosome 3q29. Two recent reports 
describe the apparent reciprocal microduplication event: 
the first, in the heterozygous state in five individuals of a 
three-generation pedigree (Lisi et al .,  2008), and the second 
including 19 cases, five of which appear to be the reciprocal 
event with the remainder overlapping this region (Ballif et 
al .,  2008). Here, we describe index cases from four pedigrees 
(Case 1 apparently de novo, Case 2 a mother-child inheri-
tance, Case 3 a nuclear family with multiple members car-
rying the duplication, and Case 4 an adopted child from 
whom information about the biological parents is unavail-
able). These cases all have microduplication of chromosome 
3q29, validated by fluorescent in situ hybridization (FISH), 
array-CGH, MLPA and/or high-resolution DNA SNP mi-
croarrays. Regardless of the initial discovery and validation 
techniques, we have also analyzed these individuals with 
genome-wide Affymetrix 500K SNP arrays in order to pro-
vide fine-map duplication breakpoints and ascertain other 
CNV events in their genomes. The clinical phenotypes of 
these patients are described in detail. Of interest, two have 
significant ophthalmological findings and developmental 
delay was frequent, suggesting that dosage sensitivity of 
genes located within 3q29 might be important for eye and 
cognitive development.  
 Clinical report 
 Case 1 (Toronto) 
 This patient is a 23 month old girl ( Fig. 1 a), who was born 
to healthy, non-consanguineous parents. The family history 
was negative for congenital anomalies (see pedigree,  Fig. 2 a). 
The pregnancy was complicated by hyperemesis for the first 
five months and hypertension for the last two weeks. There 
were no known teratogenic exposures. Fetal ultrasounds at 
9 and 20 weeks of gestation were reportedly normal. The 
patient was born at 36 weeks gestation via spontaneous vag-
inal delivery. Labour and delivery were uncomplicated with 
no neonatal resuscitation required. Apgars were nine at one 
and five minutes. The birth weight was 2,580g (50 th –75 th 
centile), length was 50 cm (90 th centile), and head circumfer-
ence was 31.5 cm (25 th centile). Multiple congenital anoma-
lies noted at birth included a large anterior fontanel, a high 
forehead with bitemporal narrowing, a downslanting right 
palpebral fissure, simple low-set ears, a broad nasal root and 
slit-like nares, a deeply grooved philtrum, thin upper lip 
and short neck with redundant nuchal skin ( Fig. 1 a). She 
had a U-shaped cleft of the secondary palate. Extensive oph-
thalmologic abnormalities included bilateral microphthal-
mia, a right iris coloboma, right corneal clouding consistent 
with a Peter’s anomaly, and a cataract of the left eye. There 
was a 2 cm umbilical hernia. The anus was simple and an-
teriorly displaced. An abdominal ultrasound revealed a cyst 
of unknown etiology located at the right crest of the dia-
phragm. Examination of the extremities revealed partial 
2–3 toe syndactyly bilaterally, sandle-gap bilaterally, and 
camptodactyly of the toes. A skeletal survey in the newborn 
period revealed bilateral proximal radial-ulnar synostosis. 
MRI of the brain at birth revealed absence of the inferior 
cerebellar vermis with an enlarged cisterna magna, consis-
tent with a Dandy-Walker variant. There were also multiple 
small cystic changes of the periventricular white matter 
within the frontal horns of the lateral ventricles. An echo-
cardiogram at birth was reported as normal; however re-
evaluation at approximately one month of age for a persis-
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tent murmur revealed an 8 mm secundum atrial septal 
 defect with left to right shunting, which has remained as-
ymptomatic since birth. 
 Abdominal ultrasound at 5 weeks of age further defined 
her abdominal cyst as arising from the stomach wall and 
wrapping around the inferior vena cava. The cyst was re-
sected and she had an unsuccessful attempt at umbilical 
hernia repair. She has had severe gastroesophageal disease 
and feeding difficulties since birth, requiring multiple high 
dose antireflux medications. Conductive hearing loss was 
detected at 6 months of age and required the insertion of 
myringotomy tubes. She underwent a right corneal trans-
plant and left cataract excision at 4 months of age. With the 
use of a contact lens in the left eye, her visual acuity was 
20/190 in the left eye and 20/960 in the right eye. A 2.7 ! 
2.8 cm subcutaneous mass was noted on the posterior right 
thigh. CT scan of the mass suggested that it was likely a 
hemangioma. No medical intervention was required. 
Growth parameters at 8 months of age revealed weight less 
than the 3 rd centile, length at the 25 th centile, and head cir-
cumference just below the 50 th centile. Her physical fea-
tures, including microphthalmia, were similar to her new-
born exam. There was central hypotonia. At 18 months of 
age, the patient’s first tooth erupted. Tooth shape was nor-
mal. A repeat attempt at surgical repair of the umbilical her-
nia and her extensive diastasis recti was successful at 20 
months of age.
a c
d
b
 Fig. 1. Clinical presentation photographs. Consent for publication was ob-
tained in all cases. ( a ) Case 1, ascertained in Toronto, Canada (newborn, left 
panel; at age 23 months, right panel). ( b ) Case 2, ascertained in Edinburgh, 
UK. Detail of left eye abnormalities shown (lower panel). ( c ) Case 3, ascer-
tained in Leiden, The Netherlands. ( d ) Case 4, ascertained in Toronto, Can-
ada, at age 11 (top panels). Details of ears are shown (bottom panels). 
Cytogenet Genome Res 123:65–78 (2008)68
 Developmental concerns were noted in the first year of 
life as she had significant hypotonia and visual impairment. 
She was smiling at 3 months of age, reaching and grasping 
at 8 months of age. She began rolling over at eight months. 
Following her surgery at 20 months, she began to sit inde-
pendently, crawl and stand with support. She had a formal 
communication assessment at 15 months of age which indi-
cated that her receptive language abilities were in the 7–9 
month old range, and her expressive skills were in the 5 
month old range. She was babbling at 23 months but did not 
yet have specific words. She receives occupational therapy, 
speech therapy, and is enrolled in an infant development 
program. 
 Case 2 (Edinburgh) 
 This girl was the first child of non-consanguineous par-
ents. She was born by spontaneous vaginal delivery weigh-
ing 3,080g (12 th percentile) at 41 weeks of gestation. An in-
creased nuchal translucency was noted during the pregnan-
cy but no invasive testing or detailed ultrasound examination 
was carried out. She was noted to be hypotonic soon after 
birth and was admitted to the neonatal intensive care unit. 
A cardiac ultrasound demonstrated an atrioventricular sep-
tal defect. She was thought to have facial dysmorphism 
compatible with a diagnosis of Down syndrome but chro-
mosome analysis revealed a 46,XX apparently normal fe-
male karyotype. At this point she was reviewed by a clinical 
geneticist (DRF) who noted significant craniofacial dys-
morphisms including upslanting palpebral fissures, large 
anterior fontanelle, brachycephaly, hypoplastic supraorbital 
ridges and a depressed nasal root ( Fig. 1 b). Her eye exami-
nation was remarkable with a left sided iris ‘coloboma’ 
caused by segmental aniridia with no evidence of an optic 
fissure closure defect. Her occipito-frontal cirumference at 
one week of age was 34 cm (25 th percentile). She had minor 
digital dysmorphisms with 5 th finger clinodactyly and mild 
syndactyly of the 2 nd and 3 rd toes on the left foot. She had 
unusual buttock folds. At this point she had further inves-
tigations including FISH for deletion 22q11.2 and Smith-
Magenis syndrome, a full skeletal survey, a diasiallotrans-
ferrin assay for congenital disorders of glycosylation, and 
quantitative plasma amino acid urinary organic acids anal-
ysis, all of which were normal. She had an emergency admis-
sion for four different infective episodes during the first five 
months of life: bronchiolitis, adenovirus pneumonia, pneu-
mococcal conjunctivitis and  Clostridium difficile . At the age 
of seven months she had an elective repair of her AVSD and 
a secundum atrial septal defect. She had a prolonged recov-
ery in intensive care and required continuous inotropic sup-
port for 38 days following the operation. 
 She had a Griffiths assessment at the age of 10 months 
and 24 days which showed global developmental delay with 
a developmental age equivalence for locomotor 2.75 mo., 
personal and social 3.5 mo., hearing and language 6.5 mo., 
eye and hand coordination 4.5 mo. and performance 3.5 
mo. She was noted to have a mild ataxia and a brain MRI at 
the age of 4.3 years showed a small cerebellar vermis. When 
last reviewed at the age of 8.6 years her height was –3.3 SD, 
weight 21 st percentile and OFC –3.2 SD. She is a very pleas-
ant and friendly girl who was in good general health. She 
remains hypotonic and mildly ataxic. She speaks in sen-
tences and has no behavioural problems. She attends a spe-
cial educational establishment where she is making prog-
ress with all aspects of her development but she has signifi-
cant global cognitive impairment. 
 The proband’s mother and 19-year-old maternal half-
sister were both healthy (See pedigree,  Fig. 2 b). The mother 
had a subsequent pregnancy that resulted in a termination 
for multiple fetal anomalies identified on antenatal ultra-
sound scanning. An autopsy on this fetus showed esopha-
geal atresia with a tracheoesophageal fistula, a ventricular 
septal defect, truncus arteriosus, bilateral renal agenesis, bi-
dup(3)(q29)
c
dup(3)(q29)
b
dup(3)(q29)
dup(3)(q29)
renal cancer
transposition of the
great arteries
ventricular septal defect
mitral atresia
esophageal atresia
ventricular septal defect
truncus arteriosus
bilateral renal agenesis
bilateral radial aplasia
postaxial polydactyly and
I syndactyly of lower limbs
dup(3)(q29)
dup(3)(q29)
d
dup(3)(q29)
a
dup(3)(q29)
 Fig. 2. Pedigrees of cases. ( a ) Case 1.
( b ) Case 2. ( c ) Case 3. ( d ) Case 4. 
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lateral radial aplasia, bilateral postaxial polydactyly of the 
feet and bilateral syndactyly of the 2 nd /3 rd and 3 rd /4 th toes. 
The mother’s full sister, who is healthy, had a child who died 
as a result of a complex cardiac defect. The proband’s ma-
ternal half uncle had been well until the age of 45 years when 
he was diagnosed with renal cell carcinoma. 
 Case 3 (Leiden) 
 This 16 year old girl was born at term with normal birth 
weight ( Fig. 1 c). There were no neonatal feeding problems 
or hypotonia. Motor development was slightly retarded. She 
was able to walk at two years of age. There was a more severe 
delay in speech development. At 10 years of age her vocabu-
lary covered 40 words. MRI at 12 years of age showed no 
brain abnormalities. At 16 years of age the girl was not toi-
let-trained. When walking she would easily stumble over. 
She was obese and had a small, narrow forehead, straight 
eyebrows, narrow palpebral fissures, hypotelorism, open 
mouth appearance, crowding of the teeth and low posterior 
hairline. There was profound mental retardation. 
 Both brothers of this girl attended special schools be-
cause of learning difficulties (See pedigree,  Fig. 2 c). The fa-
ther of the girl lives in an institution. His IQ is 64. He is un-
able to read or write. He has straight eyebrows, deep set eyes 
and narrow palpebral fissures.
 Case 4 (Toronto) 
 The proband is an adopted male who was thirty years of 
age at the time of last examination. He was the product of 
first pregnancy for a then 16 year old mother, who gave him 
up for adoption soon after birth. He was born at full term 
via vaginal delivery in breech presentation with a birth 
weight of 2,150 g (below 3 rd centile). He was noted at birth 
to have micrognathia, significant limb reduction defects of 
four extremities, congenital right hip dislocation, grade 1 
hypospadias and left cryptorchidism. At 17 months of age 
his weight was 5.4 kg (well below the 3 rd centile), head cir-
cumference 45.5 cm (–2 SD); he had mild dysmorphisms 
described as a hypoplastic mandible with overbite as well as 
mild developmental and significant speech delay. Cardiac 
evaluation revealed a grade 2/6 systolic murmur, but his 
EKG was normal. His hearing was tested at two years of age 
and was low-normal, with very mild conductive hearing 
loss in the left ear. ENT evaluation at 4 years of age ( Fig. 1 d) 
revealed a narrow, high vaulted palate with submucous cleft 
palate and very mild tongue coordination difficulties. He 
was assessed by ophthalmology at eight years of age and was 
found to have slight nystagmus, visual acuity of 20/20 and 
no structural eye defects. At age 11 ( Fig. 1 d), he was assessed 
by the craniofacial service because of severe class II maloc-
clusion and underwent extensive orthodontic treatment 
and surgery including LeFort 1 to intrude the maxilla, man-
dibular sagittal split advancement and vertical reduction 
with advancement genioplasty. At 15 years of age he had left 
inguinal exploration that revealed an atrophic testis that 
was removed. 
 The patient has mild developmental delay and learning 
disabilities. His milestones were delayed and he did not sit 
by himself until 2 years of age. At 34 months of age he was 
performing at the level of a 20 month old, with prominent 
speech delay. The patient received therapy and was able to 
attend regular school with additional help due to learning 
disabilities affecting his reading comprehension. He fin-
ished high school, obtained a college degree, and now lives 
independently and works in customer care services.
 At last examination at 30 years of age his head circumfer-
ence was 58 cm (+ 2SD); his features include a broad nasal 
bridge, high arched palate; ears that are normally placed but 
have simple, pointed pinnae with a thin upper border. He has 
increased adipose tissue and has developed multiple stria in 
the torso and abdomen. His extremities show significant 
transverse reduction defects. His most well developed limb 
is his upper right arm which includes a normal humeral arm 
segment and a partly developed forearm that extends 20 cm 
below the elbow and ends on a blind stump. The left arm and 
both legs consist only of proximal segments. All extremities 
have dermatoglyphic patterns at the tips, suggesting at least 
partial development of the hands and feet. However, no dig-
its or metacarpals are appreci ated.
 Materials and methods 
 Case 1 (Toronto) 
 PHA-stimulated lymphocytes from peripheral blood were cultured 
for 72 h with thymidine synchronization. GTG-banding analysis was 
performed on peripheral blood lymphocytes using standard cytoge-
netic techniques. G-banded karyotypes at 500 band resolution were 
prepared for the patient and both of her parents. The de novo change 
in our patient was further evaluated using fluorescent in situ hybrid-
ization (FISH). FISH was performed on cultured lymphocytes using 
the following probes: a chromosome 3q subtelomeric probe (Oncor, 
Gaithersburg, MD), and BAC clones RP11-159K3 and RP11-962B7, di-
rectly labeled with Spectrum Orange and Spectrum Green, respective-
ly ( Figs. 3 and 4). Hybridized metaphase spreads were analyzed using 
a Zeiss Axioplan 2 epifluorescence microscope. Images were captured 
by an Axiocam MRm Camera (Imaging Associates, Bicester, UK) and 
analyzed using an imaging system with MetaSystems Isis Software ver-
sion 5.1.110 (Boston, MA). 
 Case 2 (Edinburgh) 
 The 3q29 duplication in the proband was initially discovered with 
the BlueGnome CytoChip V1.1 1Mb BAC-CGH array (BlueGnome 
Ltd., Cambridge, UK), which has contig coverage of microdeletion re-
gions. BAC array-CGH was performed on the proband and both par-
ents where genomic DNA from each case was labeled by random prim-
ing. Hybridization and washes were performed on an HS 400 TM Pro 
hybridization station (Tecan Ltd., UK). Each subarray was prehybrid-
ized for 45 min at 37°C with 1.5   g of herring sperm DNA (Sigma-Al-
drich, UK) in 75   l of hybridization buffer (50% formamide, 7% dex-
tran sulphate, 2 ! saline sodium citrate (SSC), 10 mM Tris-HCl pH 7.5, 
and 0.1% (v/v) Tween 20). Test and reference samples were mixed, co-
precipitated, and resuspended in a 75   l hybridization solution that 
also contained 2.5   g/  l Cot-1 DNA (Invitrogen), denatured at 75  °  C 
for 15 min, incubated for 2 h at 37 °  C to block repetitive sequences, and 
hybridized for 21 h. Post-hybridization washes were performed using 
three wash cycles in each of PBS, 0.05% Tween at 37  °  C, 0.1 ! SSC at 
54  °  C, 1 ! PBS at 37  °  C, and a final wash in PBS, 0.05% Tween at 23  °  C. 
Slides were dried using high purity nitrogen. Arrays were scanned us-
ing a GenePix Pro 5.0 array scanner (Axon Instruments, UK) and ana-
lysed using BlueFuse for Microarrays analysis software version 3.4 
(BlueGnome Ltd, UK). 
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 The proband, an unaffected sister (age 19) and mother, as well as an 
uncle who has renal cancer at the age of 49 and a maternal aunt and her 
child who died with complex congenital heart disease were also assayed 
by MLPA. Confirmatory MLPA was performed using both P036B and 
P070 human telomere assays (MRC Holland, Netherlands), which con-
tain two independent probes for the 3q29 region. The P036B probe is 
situated in the  BDH gene on 3q. The proximal probe sequence was GC-
CACCGGGAGGAACTGGGCCAT and the distal probe sequence TC-
TAACACCCGTTGCTACCATGCTGGCCACCCGCCTCTCCAGA. 
The second probe on 3q, P070, is located in  KIAA0226 and has a prox-
imal probe sequence 5  -CTCTTTCTCCAGGTCACTGCGCTGGAG-
GACAG and distal probe sequence  5  -ATGTGCCGTCTTGTCCT-
GCCTGTTTCACATCAGCATAGGATCA. MLPA products were pro-
cessed using an ABI 3100 Genetic Analyzer with ABI GeneScan TM 
ROX500 TM size standard. Quantitative data analysis was obtained us-
ing the SoftGenetics  Gene Marker  v1.4 software.
 Case 3 (Leiden) 
 Conventional cytogenetic analysis on GTG-banded chromosomes 
from cultured lymphocytes of the index case was performed according 
to standard techniques. Array-CGH was performed on all five family 
members using the   1.0 Mb spaced whole genome large insert clone 
arrays, for which the clones were kindly made available by the Well-
come Trust Sanger Institute (http://www.sanger.ac.uk). The clones 
were grown, PCR amplified and spotted as previously described 
(Fiegler et al . , 2003; Knijnenburg et al .,  2005). Genomic DNA of the 
patient was isolated using standard techniques, and 500 ng was labeled 
with Cy3-dCTP (GE Healthcare, Diegem, Belgium) using the BioPrime  
DNA Labeling System (Invitrogen, Breda, the Netherlands). As a refer-
ence DNA, 500 ng female human genomic DNA (Promega, Leiden, the 
Netherlands) was labeled using Cy5-dCTP. Hybridization and slide 
washing was performed without prehybridization on an HS400 hy-
bridization station (Tecan, Giessen, the Netherlands). Arrays were 
scanned with a GenePix 4100A scanner (Axon Instruments, Union 
City, CA) and images were processed with GenePix Pro 4.1 software. 
Final analysis of the intensity ratios of the hybridized DNA was as pre-
viously described (Knijnenburg  et al .,  2005).
 Confirmatory MLPA was performed on the index case as described 
(White et al .,  2004). The selected probes were located in the  NCBP2 
gene. The proximal sequence was 5  -GGCCGCGGGAATTCGATTG-
GTGATGTTCTTCAGCAAATTCAACAGGCCAAAGGAGTGTTT 
and the distal sequence was 5  -GTCACTGACAGAGCTCTCAC-
CACTCACACTAGTGAATTCGCGGC.
 Quantitative readout was performed with an ABI 3730 DNA ana-
lyzer. The accompanying Genescan 3.5 software was used for peak 
analysis and further downstream normalization and calculations were 
performed as described (White  et al .,  2004). Two-colour interphase 
FISH confirmation of the duplication in the proband was performed 
with clones CTC-196F4 at 3q29, partly overlapping the  DLG1 gene (as 
in Willatt et al .,  2005), and 3p subtelomeric clone GS-1186B18 as a con-
trol.
0
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exon 7
TLN1,
exon 48
CBP,
exon 2
NCBP2,
exon 4
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exon 3
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c d e
b
 Fig. 3. Confirmatory studies of duplications. ( a ) FISH confirmation 
in Case 1, showing duplication of BAC probes RP11-962B7 (green) and 
RP11-159K3 (red). ( b ) FISH in Case 1. Cohybridization of RP11-962B7 
and RP11-159K3, demonstrating a tandem, directly oriented duplica-
tion. ( c ) FISH in Case 1, showing two copies of the 3q subtelomeric 
probe (green). ( d ) FISH confirmation in Case 3, showing duplication 
of probe CTC-196F4 (red) but not of control probe GS-1186B18 (green). 
( e ) MLPA confirmation in Case 3 and family members. The MLPA 
probe in the  NCBP2 gene shows a 3: 2 ratio in the proband, the father 
and both brothers, while the control probes located elsewhere in the 
genome show a normal 2: 2 ratio. The mother shows no duplication of 
the  NCBP2 MLPA probe. 
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 Case 4 (Toronto) 
 Routine cytogenetic workup was as for Case 1, above. The initial 
karyotype report of 46,XY was followed up with chromosomal micro-
array analysis (Kleberg Cytogenetics Laboratory, Baylor College of 
Medicine, Houston, TX, USA; CNV version 5.0).
 Affymetrix genome-wide SNP array and copy number analyses 
 For CNV analysis, we adhered to recommended guidelines (Sche-
rer et al .,  2007). In order to maximize consistency between samples 
collected at the three sites (Toronto, Leiden and Edinburgh), all sam-
ples were characterized with the Affymetrix 500K array set at The Cen-
tre for Applied Genomics in Toronto. Each sample was genotyped with 
the GeneChip  Human Mapping  Nsp I and  Sty I Arrays (Affymetrix, 
Inc., Santa Clara, CA) according to the manufacturer’s instructions 
and as described previously (Kennedy et al .,  2003). For copy number 
determination, we used three approaches: DNA Chip Analyzer (dChip) 
(Li and Wong, 2001; Lin et al .,  2004; www.dchip.org), CNAG (Nannya 
et al .,  2005) and GEMCA (Komura et al .,  2006). The first two algo-
rithms were applied separately to each 250K array, and GEMCA was 
applied to combined 500K array data. CNVs were scored if they were 
detected in the same individual either a) on both arrays, or b) by two 
of the algorithms. In our hands, these criteria result in high confidence 
CNV calls that are  1 95% likely to be confirmed by an independent 
technology such as qPCR (Pinto et al .,  2007; Marshall et al .,  2008). In 
the cases of copy number losses, SNP genotypes were examined in or-
der to determine parent of origin.
 Results 
 All phenotype and CNV data are entered in the Database 
of Chromosomal Imbalance and Phenotype in Humans us-
ing Ensembl Resources (DECIPHER; http://decipher.sanger.
ac.uk/).
 Fig. 4. Microduplication region at 3q29. Scale at the top is in mil-
lions of base pairs (NCBI Build 35). The duplicated regions in four 
cases are shown (blue bars). The approximate location of the duplica-
tion described previously is shown (Lisi et al., 2008). The region of re-
current 3q29 microdeletion described in Willatt et al. (2005) is also 
indicated (white bar); this corresponds to the duplication reported in 
Ballif et al. (2008). Feature tracks from the Database of Genomic Vari-
ants are shown below: known genes (arrow indicating direction of 
transcription), segmental duplications (SD), SNPs on the Affymetrix 
500K array set (red triangles:  Nsp I array; green triangles:  Sty I array) 
and previously reported copy number variants (CNVs; orange bars). 
Locations of BAC clones used for FISH mapping (Case 1) or duplicated 
on BAC-CGH array (Cases 3, 4) are also indicated. Duplicated probe 
CTC-196F4 in Case 3 is located within BAC clone RP5-1061C18 (shown 
here; see also Willatt et al, 2005). 
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 Case 1 (Toronto) 
 A subtle cytogenetically detectable difference  at 3q29 
was detected at a G-band resolution of 500 bands in Case 1. 
This alteration was not observed in her parents’ chromo-
somes at the same resolution (data not shown). The chromo-
somal difference was determined to be interstitial as the 
chromosome 3q subtelomeric probe revealed two normal 
signals in the correct position in this patient ( Fig. 3 c). Fur-
ther investigation using the Affymetrix 250K  Nsp I Array 
revealed a 2.4 Mb duplication of 3q29 ( Fig. 4 ;  Table 1 ). The 
duplication was determined to be de novo, as neither parent 
revealed a CNV at this locus.
 The patient also had a 60 kb loss at 6q16.1 and a 407 kb 
gain at 8p23.1 ( Table 1 ). The 6q16.1 locus contains no known 
genes and overlaps numerous known segmental duplica-
tions and CNVs, and the 8p23.1 region is a locus of known 
copy-number polymorphisms and segmental duplications 
in the vicinity of the beta-defensin gene  DEFB130 . This 
CNV overlaps with the proximal end of the region of 8p23.1 
duplication reported by Barber et al. (2008) (see Discus-
sion). Interphase FISH analysis of the 3q29 region using 
BAC clone probes RP11-159K3 and RP11-962B7 revealed 
three signals for each probe, confirming the duplication 
( Fig. 3 a). Clone RP11-962B7 is located approximately in the 
middle of the region identified as a duplication by microar-
ray, while clone RP11-159K3 is located approximately 600 
kb distal to RP11-962B7, also within the duplicated region 
in this patient ( Fig. 3 ). Co-hybridization of the two BAC 
clone probes suggested that the structure of the rearrange-
ment was a tandem, direct duplication ( Fig. 3 b). The parents 
of this patient had the normal two signals for each probe, 
confirming that the duplication occurred de novo in our 
patient (data not shown). These same FISH probes were hy-
bridized to metaphase spreads which confirmed their local-
ization to 3q29 only, in both the patient and her parents 
(data not shown).
 In order to rule out non-paternity (and thus the possibil-
ity that the 3q29 microduplication was in fact inherited, 
rather than de novo), we used PedCheck (O’Connell and 
Weeks, 1998) to detect markers incompatible with the ped-
igree. Of the 262,264 SNPs on the  Nsp I array, 271 autosomal 
and 20 X chromosome SNPs were inconsistent either be-
tween the father or mother and the proband. Of the autoso-
mal SNPs, 117 were inconsistent between mother and child, 
115 between father and child, and 39 were consistent be-
tween the child and each parent separately, but not as a pair. 
Since the proportion of incompatible markers is low (  0.1%), 
the pedigree is consistent with the SNP data. Moreover, the 
rates of inconsistency between mother and child (43.2%: 
117/271) versus father and child (42.4%: 115/271) are nearly 
identical, indicating that these are due to random genotyp-
ing errors and ruling out non-paternity in this family.
 Case 2 (Edinburgh) 
 High resolution SNP array analysis confirmed a duplica-
tion at 3q29 of 2.08 Mb in size in the proband as detected 
originally using a 1 Mb BAC array platform. Notably, the 
distal boundary was identical to that of Case 1, although the 
proximal breakpoint was slightly farther distal, accounting 
for the difference in size (2.08 Mb vs. 2.4 Mb in Case 1; see 
 Fig. 4 ). However, the unaffected mother and a maternal 
half-sister carry the apparently identical duplication, as 
does a maternal half-uncle who has renal cancer at the age 
of 45. No imbalance of the 3q29 region was evident in the 
proband’s father as seen by BAC array-CGH or MLPA. The 
mother and proband were evaluated with Affymetrix 500K 
SNP arrays and their duplications were found to be identical 
in extent ( Table 1 ). Unfortunately there was no material 
from the subsequent affected fetus of this mother to test for 
the duplication. A maternal aunt, and her child who died 
with complex congenital heart disease, do not have the du-
plication (as assayed by MLPA; data not shown; see pedi-
gree,  Fig. 2 b) and thus this heart disease in the extended 
family does not appear to be related to the 3q29 duplication. 
CNVs detected in the proband (at 7q11.23, 14q11.2, 14q21.1, 
15q11.2 and 17q21.31) and mother (7q11.23 and 14q21.1) are 
previously reported polymorphic CNVs found in apparent-
ly healthy individuals ( Table 1 ) and are thus unlikely to con-
tribute to the phenotype seen in this patient. The   360 kb 
loss at 14q21.1 and 420–430 kb gain at 14q21.1 are also pres-
ent in the proband’s unaffected mother.
 Case 3 (Leiden) 
 BAC-CGH analysis confirmed that the proband, her fa-
ther and two affected brothers carry duplications of BAC 
clones RP11-252K11 and RP11-114F20 (data not shown; see 
 Fig. 4 ). SNP microarray analysis demonstrated an identical 
1.9 Mb duplication at 3q29 in these individuals ( Table 1 ). The 
proximal boundary was identical to that of Case 1, and the 
distal boundary was somewhat more proximal ( Fig. 4 ). Oth-
er CNVs detected in this family include loci at 1q31.3, 4q24, 
7q11.23, 10q11.22, 12q24.31, 14q11.2, 14q21.1, 15q11.2, 
17q21.31, 19q13.42, all of which overlap known CNVs found 
in apparently healthy individuals ( Table 1 ). An apparent de 
novo loss at 15q11.2 in the proband was not supported by ex-
amination of genotype data, as 16 SNPs in this region were 
heterozygous (data not shown); as this is in a complex region 
including multiple similar odorant receptor genes, this CNV 
may be a false positive, or may represent a loss to two copies 
as compared with higher copy number in other members of 
this family. One additional CNV in this family, at 
8p23.2 ] p23.1, is also in a region of known CNVs and is prox-
imal to the microduplication 8p23.1 region described by Bar-
ber et al. (2008) (see Discussion). The duplication in the pro-
band was confirmed by two-colour interphase FISH ( Fig. 3 d). 
The MLPA probe in the  NCBP2 gene also confirmed the du-
plication (3: 2 ratio as compared with control) in the father 
and both brothers, while control probes located elsewhere in 
the genome show a normal 2: 2 ratio. The mother showed no 
duplication of the  NCBP2 MLPA probe ( Fig. 3 e).
 Case 4 (Toronto) 
 BAC-CGH array analysis revealed a gain in copy number 
of two clones (RP11-447L10 and RP11-432D10;  Fig. 4 ) lo-
cated at cytogenetic band 3q29, with no other sites of copy 
number change detected. Microarray analysis demonstrat-
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Cytoband Estimated size
(bp)
Type Status in childrena Gene(s) involved
Family of Case 1
Proband
3q29 2,399,433 gain de novo multiple genes; overlapping with 3q29 microdeletion syndrome 
(Willatt et al., 2005)
6q16.1 60,058 loss inherited (paternal)b no genes; overlaps known CNVs
8p23.1 407,187 gain inherited (maternal) FAM86B1, DEFB130, LOC44005; region of segmental duplications and 
known CNVs
Mother
8p23.1 202,167 gain – no known genes; numerous cDNAs; region of segmental duplications and 
known CNVs
10q11.1-q11.21 906,591 gain – ZNF33B, BMS1L and numerous cDNAs; region of segmental duplications 
and known CNVs
11q22.1 626,031 loss – cDNA AK128111; overlaps known CNVs
15q11.2 1,908,357 loss – OR4N2, OR4M4, POTE15, LOC283755 and multiple cDNAs
22q11.23 211,233 gain – LRP5L and multiple cDNAs; region of segmental duplications and known 
CNVs
Father
6q16.1 60,058 loss – no genes; overlaps known CNVs
10q11.22 124,801 gain – no genes; region of  segmental duplications and known CNVs
14q11.2 153,147 gain – OR4N2, OR4K2, OR4K5, OR4K1 (odorant receptor gene cluster)
Family of Case 2
Mother
3q29 2,086,988 gain – multiple genes; overlapping with 3q29 microdeletion syndrome 
(Willatt et al., 2005)
7q11.23 428,467 gain – POMZP3, UPK3B, cDNA BC043544, intron of cDNA BC013192
14q21.1 357,718 loss – cDNA BX248273; encompasses small CNV
Proband
3q29 2,086,988 gain inherited
(apparently maternal)
multiple genes; overlapping with 3q29 microdeletion syndrome 
(Willatt et al., 2005)
7q11.23 422,126 gain inherited
(apparently maternal)
POMZP3, most of UPK3B, cDNA BC043544, intron of cDNA BC013192
14q11.2 219,459 gain unknown OR4Q3, OR4M1, OR4N2, OR4K2, OR4K5, OR4K1 (odorant receptor cluster)
14q21.1 368,345 loss inherited
(maternal)b
cDNA BX248273; encompasses small CNV
15q11.2 1,662,281 gain unknown OR4N2, OR4M4, POTE15, LOC283755 and multiple cDNAs
17q21.31 183,068 gain unknown 5 end of KIAA1267, and cDNAs BC018467 and BC000924
Family of Case 3
Proband
3q29 1,893,889 gain inherited (paternal) multiple genes; overlapping with 3q29 microdeletion syndrome 
(Willatt et al., 2005)
8p23.2-p23.1 176,963 gain inherited (paternal) 5 end of MCPH1, and cDNAs including AK025595
15q11.2 1,378,020 loss de novoc OR4N2, OR4M4, POTE15, LOC283755 and multiple cDNAs
19q13.42 456,306 gain inherited (maternal) cDNA BX248273; encompasses small CNV
Mother
12q24.31 114,901 gain – 3 ends of P2RX7 and CAMKK2, and all of P2RX4
19q13.42 996,692 gain – multiple genes
brother 1
1q31.3 142,667 loss inherited (paternal)d CFHR3, CFHR1 and 5 end of CFHR4
3q29 1,893,889 gain inherited (paternal) multiple genes; overlapping with 3q29 microdeletion syndrome
(Willatt et al., 2005)
8p23.2-p23.1 221,809 gain inherited (paternal) 5 end of MCPH1, and cDNAs including AK025595
10q11.22 1,087,629 gain inherited (paternal) GPRIN2, PPYR1, ANXA8L1, ANXA8, and multiple other cDNAs
12q24.31 79,614 gain inherited (maternal) 3 ends of P2RX7 and CAMKK2, all of P2RX4
14q11.2 229,920 gain inherited (paternal) OR4Q3, OR4M1, OR4N2, OR4K2, OR4K5, OR4K1
(odorant receptor gene cluster)
15q11.2 1,662,281 gain de novoc OR4N2, OR4M4, POTE15, LOC283755 and multiple cDNAs
19q13.42 857,878 gain inherited (maternal) multiple genes
Table 1. CNVs detected in patient families with Affymetrix 500K microarrays
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ed a duplication of 2.0 Mb at 3q29 ( Table 1 ). The proximal 
boundary was similar to those of Cases 1 and 3, and the dis-
tal boundary just slightly distal to that of Case 3 but still 
within a cluster of segmental duplications ( Fig. 4 ). Other 
CNVs detected in this individual that are also seen in healthy 
individuals were at 2q27.3, 14q11.2 and Xp11.23 ( Table 1 ). 
One additional large (2.6 Mb) CNV at 6q24.2 ] q24.3 en-
compasses several small known CNVs but also results in a 
previously unreported copy number gain of a number of 
known genes including Utrophin ( UTRN ), the Lafora pro-
gressive myoclonus epilepsy gene  EPM2A , a metabotropic 
glutamate receptor ( GRM1 ), Ras oncogene family member 
 RAB32 , two genes apparently involved in protein ubiqui-
tination ( SHPRH and  FBXO30 ) and an expressed repetitive 
element ( FLJ44955 ).
 Discussion 
 Duplication 3q syndrome (dup3q) has been described in 
the literature, consisting of dysmorphic features including 
microcephaly, low-set ears, downturned corners of the 
mouth, bushy eyebrows and long eyelashes, along with eye, 
palate, renal and cardiac anomalies (Steinbach et al .,  1981; 
Aqua et al .,  1995). The phenotype has been said to partially 
overlap that of Brachmann de Lange/Cornelia de Lange 
syndrome (OMIM#122470). Many groups have described 
the cytogenetic critical region associated with the 3q dupli-
cation syndrome as involving 3q26 (Aqua et al .,  1995; Rizzu 
et al .,  1997; Faas et al .,  2002); however Battaglia et al. (2006) 
suggested that it was 3q29. The four index patients which we 
have presented do not have a phenotype consistent with 
Brachman de Lange syndrome, suggesting that 3q29 is un-
likely to be involved in the previously described ‘Duplica-
tion 3q syndrome’. 
 Prior to the past year, there were few cases described with 
pure duplications of chromosome 3q. Faas et al. (2002) de-
scribed three patients with cytogenetically visible chromo-
some 3q duplications that extended to include 3q29. The 
duplications in these patients included more proximal cy-
togenetic bands in addition to 3q29, whereas our reported 
cases had small duplications localized within 3q29; how-
ever, features common to both groups included mental re-
tardation and ocular anomalies.
Cytoband Estimated size
(bp)
Type Status in childrena Gene(s) involved
Brother 2
3q29 1,893,889 gain inherited (paternal) multiple genes; overlapping with 3q29 microdeletion syndrome 
(Willatt et al., 2005)
4q24 831,405 gain inherited (paternal) TACR3
8p23.2-p23.1 198,636 gain inherited (paternal) 5 end of MCPH1, and cDNAs including AK025595
10q11.22 848,700 gain inherited (paternal) SYT15, GPRIN2, PPYR1, ANXA8L1
15q11.2 1,662,281 gain de novoc OR4N2, OR4M4, POTE15, LOC283755 and multiple cDNAs
19q13.42 541,228 gain inherited (maternal) multiple genes
Father
3q29 1,893,889 gain – multiple genes; overlapping with 3q29 microdeletion syndrome 
(Willatt et al., 2005)
4q24 556,763 gain – TACR3
8p23.2-p23.1 224,359 gain – 5 end of MCPH1, and cDNAs including AK025595
10q11.22 848,700 gain – SYT15, GPRIN2, PPYR1, ANXA8L1
14q11.2 222,787 gain – OR4Q3, OR4M1, OR4N2, OR4K2, OR4K5, OR4K1 (odorant receptor gene 
cluster)
Case 4
2q27.3 81,134 loss unknown multiple cDNAs; encompassed by known CNV
3q29 2,041,109 gain unknown multiple genes; overlapping with 3q29 microdeletion syndrome 
(Willatt et al., 2005)
6q24.2-q24.3 2,637,073 gain unknown 3 end of UTRN, EPM2A, GRM1, RAB32, FLJ44955, FBX030, SHPRH,
various cDNAs; encompasses several small CNVs
14q11.2 249,343 loss unknown OR4N2, OR4K2, OR4K5, OR4K1, OR4K13, OR4K14, OR4K15 (odorant
receptor gene cluster; encompasses known CNV and segmental duplications)
Xp11.23 67,327 loss unknown ZNF630, SSX6; encompasses known CNV and segmental duplications
a Parental origin is inferred assuming Mendelian inheritance of CNV events. In Case 2, these are apparently maternal; however, the father’s 
sample was not available for analysis.
b Parental origin of losses in Case 1 and Case 2 were confirmed by examination of SNP genotypes in these regions.
c The 15q11.2 region is very complex and apparently de novo events may actually be inherited; in particular, the loss in Case 3 contains mul-
tiple heterozygous SNPs and is therefore not a simple hemizygous deletion.
d SNP genotypes are consistent with paternal inheritance of the 1q31.3 loss in this individual. The corresponding CNV in the father was iden-
tified by only one algorithm  and thus is not reported.
Table 1 (continued)
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 As molecular cytogenetic techniques have advanced over 
the recent years, we have been able to better detect and more 
precisely define microdeletions and microduplications in 
this region. The presence of microdeletions (Willatt et al., 
2005) and the abundance of segmental duplications in this 
region (in particular at approximately 196.6 and 199 Mb) 
suggested that the reciprocal microduplications might exist, 
and two recent reports (Ballif et al., 2008; Lisi et al., 2008) 
and the cases reported here support this hypothesis.
 As demonstrated by our cases, there appears to be a vari-
able clinical phenotype associated with this duplication (see 
 Table 2 ), characterized by ocular and cardiac anomalies, 
hypotonia, developmental and speech delay. However, the 
phenotype is variable with reduced penetrance; the mother 
and maternal half sister of Case 2 are unaffected, and the 
two brothers of Case 3 have milder phenotypes. Case 4 dem-
onstrates the wide spectrum of phenotypic differences, al-
though it is possible that his tetramelia may be unrelated to 
the duplication (see below). The previously reported family 
(Lisi et al .,  2008) also included individuals with some simi-
lar features, notably frequent developmental delay and some 
with palpebral fissure anomalies. The cases reported by Bal-
lif et al. (2008) had duplications varying in size from 0.2 to 
2.4 Mb, but only five of these had the apparent reciprocal 
duplication of the previously reported deletion (Willatt et 
al .,  2005). Of these, clinical information was reported for 
three, with mild to moderate developmental delay as the 
only common feature, and craniosynostosis, high palate, 
seizures and a ventricular septal defect occurring in two 
cases each (Ballif et al .,  2008). 
 Notably, the duplication events in all four of the families 
presented here overlap, and those of Cases 2, 3 and 4 each 
share one of the boundaries of Case 1, the largest of the du-
plications. Together, these define a minimum critical region 
of approximately 1.58 Mb in size, encompassing the region 
from the  TFRC to  BDH1 genes. The proximal and distal 
ends of this minimal region correspond to clusters of seg-
mental duplications ( Fig. 4 ), indicating a possible recombi-
nation-mediated mechanism for the formation of these du-
plications. The region is similar in size to the 3q29 micro-
deletions previously reported (Willatt et al .,  2005), which 
extend from BAC clone RP11-252K11 (proximal end at 
197.40 Mb) to RP11-535N19 (distal end at 198.81 Mb) (see 
 Fig. 4 ), further supporting the hypothesis that these are re-
ciprocal products of a deletion/duplication event mediated 
by non-allelic homologous recombination at segmental du-
plications (Lupski, 2004; Ballif et al .,  2008; Lisi et al .,  2008). 
This region contains 20 known genes ( Table 3 ).
 DLG1 seems to be a good candidate for the ocular aspects 
of the dup(3)(q29) phenotype (microphthalmia in Case 1, 
partial aniridia in Case 2).  DLG1 is expressed in the devel-
oping lens and retinal pigment epithelium, and a  DLG1 
gene-trap homozygous mouse has overgrowth of the lens 
epithelium as one part of the phenotype (Nguyen et al ., 
 2003). With regards to developmental delay, Willatt et al . 
 (2005) in their description of microdeletions of 3q29 in this 
region (see  Fig. 3 ) point out that two of the genes in this re-
gion,  PAK2 and  DLG1 , are homologues of the X-linked men-
tal retardation genes  PAK3 and  DLG3 . We also note that this 
region contains the  ZDHHC19 gene, a homologue of the 
 ZDHHC9 palmitoyltransferase, mutations of which have 
been shown to cause X-linked mental retardation with Mar-
fanoid habitus (OMIM 300646). Importantly, all of these 
are increased in copy number in the 3q29 duplication pa-
tients described here, whereas they are reduced to haploidy 
in 3q29 microdeletion patients. Possibly, these or other 
genes in the region are sensitive to both increases and de-
creases in gene dosage, either of which might disrupt nor-
mal development. 
 The other CNVs detected in these patients overlap previ-
ously reported polymorphic CNVs present in the general 
population (reflected by their presence in the Database of 
Genomic Variants; Iafrate et al .,  2004), with two exceptions. 
The most obvious potentially pathogenic CNV is at 8p23.1 
Table 2. Comparison of clinical features in four patients with duplication of 3q29
Clinical feature Case 1 (Toronto; 23 months) Case 2 (Edinburgh; 8 years) Case 3 (Leiden; 16 years) Case 4 (Toronto; 30 years)
Birth weight 2,850g (50–75th centile) 3,080g (12th centile) 3,200g (25th centile) 2,150g (<3rd centile)
Microcephaly – + not reported –
Generalized obesity – – + +
Ocular anomalies + + not reported –
Palpebral fissure anomalies + + + –
Cleft palate + – – +
Dental anomalies + – + +
Conductive hearing loss + – not reported +
Structural brain anomaly + + – –
Developmental delay + + + +
Hypotonia + + – –
Congenital heart disease + + – –
Musculoskeletal anomalies + + not reported +
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in Case 1, overlapping the proximal end of the region seen 
in 8p23.1 duplication syndrome patients (Barber et al ., 
 2008). This patient shares some clinical features with the 
patients of Barber et al . , notably a high forehead, cardiac 
malformations, low-set ears and partial 2/3 toe syndactyly. 
The Family 1 proband of Barber et al .  also had a high arched 
palate which could be compared to the cleft palate of our 
Case 1. We cannot rule out that some of these features seen 
in our Case 1 may be due to the overlap of the 8p23.1 CNV 
with the proximal end of the 8p23.1 microduplication re-
gion; however, there is a relatively small region of overlap 
(407 kb of   3.75 Mb total) containing only the beta-defen-
sin gene  DEFB130 and two genes of unknown function 
( FAM86B1 , and  LOC440053 which has homology to zinc 
finger protein genes). Furthermore, our Case 1 and Case 2 
probands share common anomalies and phenotypic fea-
tures, and Case 2 was not found to have an 8p23.1 CNV, 
suggesting that their similarities are more likely a result of 
their common 3q29 duplication. In contrast, the 8p23.2 ] 
p23.1 CNV seen in the family of our Case 3 is distinct, being 
located distal to this microduplication region. Although 
Barber et al. ran a custom Agilent 44K genome-wide oligo-
nucleotide CGH array on their patients (http://www.ngrl.
org.uk/Wessex/array.htm), they report no results indicating 
whether changes in the 3q29 region (or anywhere else in the 
genome other than 8p23.1) were observed.
 The second potentially pathogenic CNV is the gain at 
6q24.2 ] q24.3 seen in Case 4. This 2.6 Mb region might 
contribute to the tetramelia seen only in this patient, pos-
sibly due to the involvement of the Utrophin/Dystrophin-
like protein ( UTRN ) gene, or the putative protein-ubiquitin 
ligases  SHPRH and  FBXO30 . However, there is currently no 
experimental evidence that gains of activity or genomic 
copy number of these or the other genes in this region 
( GRM1 ,  EPM2A ,  RAB32 and  FLJ44955 ) can affect limb de-
velopment, although extensive work characterizing  UTRN 
knockouts has been performed. Given its role in normal 
muscle development, further characterization of overex-
pression of Utrophin in limb development may shed some 
light on this patient’s phenotype.
 In summary, we have described four new cases with 3q29 
duplications, with a minimum region of overlap of 1.6 Mb 
corresponding in location to the previously reported 3q29 
microdeletions. The phenotype in these families reveals 
variable expressivity and reduced penetrance. Global devel-
opmental delay was the most consistent feature in our cases 
Table 3. Genes in minimal region of 3q29 duplication
Gene Function Known syndromes/diseases MIM
BDH1 3-hydroxybutyrate dehydrogenase, type 1; interconversion of
acetoacetate and (R)-3-hydroxybutyrate during fatty acid catabolism
none –
C3orf43 unknown none –
C3orf34 unknown none –
DLG1 homologue of Drosophila tumour suppressor gene; putative
lymphocyte-specific TSG
homologous to X-linked mental retardation
gene DLG3 (Willatt et al., 2005); eye anomalies
in knockout mouse (Nguyen et al., 2003)
601014
FLJ25996 unknown none –
LRRC33 leucine rich repeat containing 33 none –
MFI2 melanoma cell surface glycoprotein; similar to transferring none 155750
MGC33212 TCTEX1D2, Tctex1 domain containing 2 none –
NCBP2 nuclear cap-binding protein 2 none 605133
OSTA organic solute transporter alpha subunit; basolateral bile acid and
steroid transporter
none –
PAK2 p21 activated kinase homologous to X-linked mental retardation
gene PAK3 (Willatt et al., 2005)
605022
PCYT1A phosphate cytidylyltransferase 1, choline, alpha isoform;
phosphatidyl choline synthesis
none (essential for survival in cultured cells) 123695
PIGX phosphatidyl inositol glycan, class X; synthesis of glycosyl-
phosphatidylinositol in the endoplasmic reticulum
none 610276
PIGZ phosphatidyl inositol glycan, class Z; synthesis of glycosyl-
phosphatidylinositol 
none 611671
RNF168 ring finger protein 168 none –
SENP5 SUMO1/sentrin specific peptidase 5; required for mitosis
and/or cytokinesis
none –
TFRC transferrin receptor 1 cellular receptor for New World hemorrhagic 
fever arenaviruses; knockout results in severe 
anemia and neurologic abnormalities in mouse 
model
190010
TM4SF19 transmembrane 4 L six family member 19 none –
WDR53 WD repeat domain 53 none –
ZDHHC19 homologue of palmitoyltransferase of NRAS and HRAS (ZDHHC9) homologous to ZDHHC9 causing X-linked
mental retardation with Marfanoid habitus
–
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and two other studies (Ballif et al . , 2008; Lisi et al . , 2008). 
Other features common to some of the patients included 
ocular anomalies, congenital heart defects, structural brain 
anomalies and hypotonia. Further phenotypic character-
ization of these patients, in combination with improved mo-
lecular understanding of the 3q29 duplicated region, will 
better delineate potential dosage sensitive genes in this ge-
nomic interval and their possible roles in cognitive and oc-
ular development.
 Management and anticipatory care 
 Management guidelines for duplication of chromosome 
3q29 have not been previously published. Our recommen-
dations are based on the phenotypes described in our new-
ly reported cases and those of the cases recently described 
by Lisi et al. and Ballif et al. in 2008. Importantly, as we dis-
cuss in this paper, the CNV content at other sites should also 
be considered in performing genotype and phenotype cor-
relations.
 Infancy and initial diagnosis:
 1) Ophthalmologic evaluation
 2) Echocardiogram
 3) Brain imaging 
 4) Developmental assessment by 6 months of age, and 
continuing every 1–3 years as needed
 5) Hearing evaluation
 6) Skeletal survey
 7) Early intervention services
 8) Offer cytogenetic/molecular testing to parents to de-
termine if the duplication of 3q29 is de novo or familial. 
Refer parents for genetic counseling if contemplating future 
pregnancies.
 9) Family support
 Childhood: 
 1) Ongoing developmental services and therapy. Individ-
ualized educational plan if appropriate. Children will likely 
benefit from speech therapy, occupational therapy, and 
physical therapy.
 2) Referral to paediatric dentistry
 3) Encourage physical activity and balanced diet, given 
reported obesity in some children/adults with duplication 
3q29
 Adolescence and adulthood:
 1) Annual medical examination as per standard medical 
practice
 2) Ongoing developmental services, individualized edu-
cational plan, and counseling regarding work placement ap-
propriate for level of development
 3) Education regarding sexual development and recur-
rence risk in offspring if appropriate for level of develop-
ment. 
 These recommendations will be updated as we learn 
more about the natural history and variable phenotype of 
this condition, as well as the impact of CNVs at different 
sites in the genome.
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